Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Trevi Therapeutics Inc (NQ: TRVI ) 3.020 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Trevi Therapeutics Inc < Previous 1 2 3 4 Next > Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock September 06, 2024 Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out? Via MarketBeat Exposures Product Safety TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024 August 08, 2024 TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session June 06, 2024 Via Benzinga TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024 May 07, 2024 TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023 March 20, 2024 TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Trevi Therapeutics: Q4 Earnings Insights March 20, 2024 Via Benzinga Earnings Outlook For Trevi Therapeutics March 19, 2024 Via Benzinga Trevi Therapeutics's Earnings: A Preview November 08, 2023 Via Benzinga Recap: Trevi Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Earnings Scheduled For March 20, 2024 March 20, 2024 Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 01, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 18, 2023 Via Benzinga Earnings Outlook For Trevi Therapeutics March 15, 2023 Via Benzinga Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial September 19, 2022 Via Benzinga Earnings Scheduled For November 9, 2023 November 09, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 18, 2023 Via Benzinga Earnings Scheduled For August 10, 2023 August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. Via Benzinga Earnings Preview: Trevi Therapeutics May 10, 2023 Via Benzinga Earnings Scheduled For May 11, 2023 May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... Via Benzinga Earnings Scheduled For March 16, 2023 March 16, 2023 Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. Via Benzinga Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 18, 2023 Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 March 14, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 April 12, 2023 Via Benzinga Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast January 25, 2023 Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... Via Newsfile Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket November 23, 2022 Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday. Via Benzinga Earnings Scheduled For November 10, 2022 November 10, 2022 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. Via Benzinga Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock November 09, 2022 Trevi Therapeutics, Inc. - Common Stock (NASDAQ:TRVI) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Via Benzinga Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday September 21, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 20, 2022 Via Benzinga Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast August 22, 2022 Phoenix, Arizona--(Newsfile Corp. - August 22, 2022) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... Via Newsfile Exposures Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.